ORIG3N is an interesting and innovative induced pluripotent stem cell (iPSC) company that describes itself as “leading a transformation in the understanding and treatment of rare, genetically inherited disease.” I am fascinated by the company, because it is one of the only biotechnology companies worldwide to bring their products and services directly to the public.
Specifically, ORIG3N has created the world’s largest uniformly consented blood cell repository, LifeCapsule, and it is using these blood cells to produce patient-specific induced pluripotent stem cells (iPSCs). In addition to collecting donated blood samples for iPSC production, ORIG3N also offers an optional LifeCapsule membership, in which the public can pay $99/year to get permanent access to their own immortalized iPSCs.
You can learn more about the company by reading this fascinating interview with James Lovgren, Chief Business Officer of ORIG3N. It was my honor to meet with him at the recent World Stem Cell Summit in Atlanta, GA. [Read more…]